NORTHAMPTON, MA / ACCESSWIRE / September 4, 2024 / Transformative medicines have the greatest impact when they reach the people who need them most.

Here, Johanna Mercier, Chief Commercial Officer, shares how Gilead works to help remove barriers to care, improve health equity and increase access to life-changing therapies - all of which underscore our commitment to being a responsible company.

Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. The company strives to transform and simplify care for people with life-threatening illnesses around the world. Gilead has operations in more than 35 countries worldwide, with headquarters in Foster City, California.

Originally published by Gilead Sciences

View additional multimedia and more ESG storytelling from Gilead Sciences on 3blmedia.com.

Contact Info:
Spokesperson: Gilead Sciences
Website: https://www.3blmedia.com/profiles/gilead-sciences
Email: [email protected]

SOURCE: Gilead Sciences

View the original press release on accesswire.com